AOD 9604 ZPHC — 25 mg (5 vials × 5 mg)

AOD 9604 — targeted fat-loss peptide
5 lyophilised vials × 5 mg (total 25 mg)

• Mechanism: fragment 176-191 analogue that boosts lipolysis and inhibits lipogenesis without elevating glucose or IGF-1.
• Reconstitution: add 1 ml bacteriostatic water → 5 mg/ml; swirl gently, do not shake.
• Storage: refrigerate 2 – 8 °C after mixing; freeze-dried powder is RT-stable during shipping.
• Sample research dosing: 250 – 500 µg sub-Q daily (split AM/PM) for 4 – 6 weeks.
• QC: ≥ 99 % purity (HPLC); endotoxin < 0.03 EU/mg; each box carries a scratch-code for authenticity.
• Cold-chain packed • tamper-evident vials • discreet, tracked worldwide delivery.